These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32048880)

  • 1. Recent development in acetyl-CoA carboxylase inhibitors and their potential as novel drugs.
    Wu X; Huang T
    Future Med Chem; 2020 Mar; 12(6):533-561. PubMed ID: 32048880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors.
    Chen L; Duan Y; Wei H; Ning H; Bi C; Zhao Y; Qin Y; Li Y
    Expert Opin Investig Drugs; 2019 Oct; 28(10):917-930. PubMed ID: 31430206
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure, function and selective inhibition of bacterial acetyl-coa carboxylase.
    Polyak SW; Abell AD; Wilce MC; Zhang L; Booker GW
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):983-92. PubMed ID: 22183085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling study for the design of novel acetyl-CoA carboxylase inhibitors using 3D QSAR, molecular docking and dynamic simulations.
    Vyas VK; Dabasia M; Qureshi G; Patel P; Ghate M
    J Biomol Struct Dyn; 2017 Jul; 35(9):2003-2015. PubMed ID: 27335214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetyl-coenzyme A carboxylases: versatile targets for drug discovery.
    Tong L; Harwood HJ
    J Cell Biochem; 2006 Dec; 99(6):1476-88. PubMed ID: 16983687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2.
    Corbett JW; Freeman-Cook KD; Elliott R; Vajdos F; Rajamohan F; Kohls D; Marr E; Zhang H; Tong L; Tu M; Murdande S; Doran SD; Houser JA; Song W; Jones CJ; Coffey SB; Buzon L; Minich ML; Dirico KJ; Tapley S; McPherson RK; Sugarman E; Harwood HJ; Esler W
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2383-8. PubMed ID: 20219367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting.
    Huard K; Smith AC; Cappon G; Dow RL; Edmonds DJ; El-Kattan A; Esler WP; Fernando DP; Griffith DA; Kalgutkar AS; Ross TT; Bagley SW; Beebe D; Bi YA; Cabral S; Crowley C; Doran SD; Dowling MS; Liras S; Mascitti V; Niosi M; Pfefferkorn JA; Polivkova J; Préville C; Price DA; Shavnya A; Shirai N; Smith AH; Southers JR; Tess DA; Thuma BA; Varma MV; Yang X
    J Med Chem; 2020 Oct; 63(19):10879-10896. PubMed ID: 32809824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential.
    Luo DX; Tong DJ; Rajput S; Wang C; Liao DF; Cao D; Maser E
    Recent Pat Anticancer Drug Discov; 2012 May; 7(2):168-84. PubMed ID: 22339356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.
    Harriman G; Greenwood J; Bhat S; Huang X; Wang R; Paul D; Tong L; Saha AK; Westlin WF; Kapeller R; Harwood HJ
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1796-805. PubMed ID: 26976583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Biological Evaluation and Molecular Docking Studies of Piperidinylpiperidines and Spirochromanones Possessing Quinoline Moieties as Acetyl-CoA Carboxylase Inhibitors.
    Huang T; Sun J; Wang Q; Gao J; Liu Y
    Molecules; 2015 Sep; 20(9):16221-34. PubMed ID: 26370948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of mammalian acetyl-CoA carboxylase.
    Corbett JW; Harwood JH
    Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):162-80. PubMed ID: 18221116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of disubstituted (4-piperidinyl)-piperazine derivatives as potent acetyl-CoA carboxylase inhibitors.
    Chonan T; Tanaka H; Yamamoto D; Yashiro M; Oi T; Wakasugi D; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3965-8. PubMed ID: 20537533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclohexanedione herbicides are inhibitors of rat heart acetyl-CoA carboxylase.
    Seng TW; Skillman TR; Yang N; Hammond C
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3237-42. PubMed ID: 12951100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acetyl-CoA carboxylase enzyme: a target for cancer therapy?
    Wang C; Ma J; Zhang N; Yang Q; Jin Y; Wang Y
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):667-76. PubMed ID: 25979092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice.
    Gao YS; Qian MY; Wei QQ; Duan XB; Wang SL; Hu HY; Liu J; Pan CY; Zhang SQ; Qi LW; Zhou JP; Zhang HB; Wang LR
    Acta Pharmacol Sin; 2020 Mar; 41(3):336-347. PubMed ID: 31645659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 4-phenoxy-phenyl isoxazoles as novel acetyl-CoA carboxylase inhibitors.
    Wu X; Yu Y; Huang T
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1236-1247. PubMed ID: 34100310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of spirocyclic-diamine inhibitors of mammalian acetyl CoA-carboxylase.
    Kung DW; Griffith DA; Esler WP; Vajdos FF; Mathiowetz AM; Doran SD; Amor PA; Bagley SW; Banks T; Cabral S; Ford K; Garcia-Irizarry CN; Landis MS; Loomis K; McPherson K; Niosi M; Rockwell KL; Rose C; Smith AC; Southers JA; Tapley S; Tu M; Valentine JJ
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5352-6. PubMed ID: 26411795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the development of acetyl-CoA carboxylase (ACC) inhibitors for the treatment of metabolic disease.
    Bourbeau MP; Bartberger MD
    J Med Chem; 2015 Jan; 58(2):525-36. PubMed ID: 25333641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors.
    Kamata M; Yamashita T; Kina A; Tawada M; Endo S; Mizukami A; Sasaki M; Tani A; Nakano Y; Watanabe Y; Furuyama N; Funami M; Amano N; Fukatsu K
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4769-72. PubMed ID: 22677317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting liver metabolism through acetyl-CoA carboxylase inhibition.
    Pérez-Díaz AJ; Núñez-Sánchez MÁ; Ramos-Molina B
    Trends Endocrinol Metab; 2024 Jul; 35(7):563-565. PubMed ID: 38664153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.